Stocksigma LogoStocksigma Logo

OneSource Receives USFDA EIR with VAI Status for Bengaluru Sterile Facility

OneSource Specialty Pharma Limited received the Establishment Inspection Report (EIR) with a 'Voluntary Action Indicated' (VAI) classification from the

OneSource Receives USFDA EIR with VAI Status for Bengaluru Sterile Facility

Onesource Specialty Pharma Ltd 路 Press Release 路 30 Oct 2026, 7:37 pm

OneSource Receives USFDA EIR with VAI Status for Bengaluru Sterile Facility OneSource Specialty Pharma Limited received the Establishment Inspection Report (EIR) with a 'Voluntary Action Indicated' (VAI) classification from the USFDA on 30th Oct'26 for its Sterile Product Division (SPD) facility in Bengaluru. This successfully closes the regulatory inspection conducted between 22nd Jun'26 and 30th Jun'26. The clearance supports the company's sterile injectable capabilities and strengthens its CDMO platform across biologics, drug-device combinations, sterile injectables, and soft gelatin capsules.

Original exchange filing (PDF)

More announcements from Onesource Specialty Pharma Ltd

All Onesource Specialty Pharma Ltd announcements